Free Trial

Spectral Medical (TSE:EDT) Share Price Crosses Above 50-Day Moving Average - Here's What Happened

Spectral Medical logo with Medical background

Spectral Medical Inc. (TSE:EDT - Get Free Report) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$0.81 and traded as high as C$0.88. Spectral Medical shares last traded at C$0.88, with a volume of 17,411 shares changing hands.

Spectral Medical Price Performance

The firm has a 50-day moving average of C$0.81 and a two-hundred day moving average of C$0.67. The company has a quick ratio of 0.45, a current ratio of 0.61 and a debt-to-equity ratio of 26.03. The company has a market capitalization of C$247.50 million, a PE ratio of -12.57 and a beta of 0.96.

Spectral Medical Company Profile

(Get Free Report)

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.

Further Reading

Should You Invest $1,000 in Spectral Medical Right Now?

Before you consider Spectral Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.

While Spectral Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines